• レポートコード:QYR2104Z4327 • 出版社/出版日:QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態:英文、PDF、92ページ • 納品方法:Eメール(納期:3日) • 産業分類:医療 |
Single User | ¥553,800 (USD3,900) | ▷ お問い合わせ |
Multi User/Five User | ¥830,700 (USD5,850) | ▷ お問い合わせ |
Enterprise License(同一法人内共有可) | ¥1,107,600 (USD7,800) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査資料では、孤児肺疾患治療のグローバル市場(2016年~2027年)について調べ、市場動向、主要企業の市場シェア、種類別市場規模(免疫抑制剤、抗炎症剤、抗線維化剤、血管拡張剤、コルチコステロイド、CFTRモジュレーター、その他)、用途別市場規模(病院薬局、ドラッグストア、オンライン薬局)、主要地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、関連企業情報などを掲載しています。 ・市場概要 ・孤児肺疾患治療の市場動向 ・企業の競争状況、市場シェア ・孤児肺疾患治療の種類別市場規模(免疫抑制剤、抗炎症剤、抗線維化剤、血管拡張剤、コルチコステロイド、CFTRモジュレーター、その他) ・孤児肺疾患治療の用途別市場規模(病院薬局、ドラッグストア、オンライン薬局) ・孤児肺疾患治療の北米市場規模2016-2027(アメリカ、カナダ) ・孤児肺疾患治療のヨーロッパ市場規模2016-2027(ドイツ、フランス、イギリス等) ・孤児肺疾患治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等) ・孤児肺疾患治療の中南米市場規模2016-2027(メキシコ、ブラジル) ・孤児肺疾患治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等) ・主要企業情報(GSK、Pfizer、Celgene、Novartis、NPS Pharmaceuticals、Auspex Pharmaceuticals、Synageva BioPharma、Roche、Sanofi) ・結論 |
Orphan illnesses are those which are not generally looked into, those where particular medicines are not accessible, and those which may just be of restricted enthusiasm to researchers and specialists.
Orphan lung diseases are exemplified by the purported disregarded infectious diseases, which are endemic to regions mainly in Africa, Asia and the Americas.
Market Analysis and Insights: Global Orphan Lung Diseases Treatment Market
The global Orphan Lung Diseases Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Orphan Lung Diseases Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Orphan Lung Diseases Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Orphan Lung Diseases Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Orphan Lung Diseases Treatment market.
Global Orphan Lung Diseases Treatment Scope and Market Size
Orphan Lung Diseases Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Orphan Lung Diseases Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Immunosuppressants
Anti-Inflammatory Drugs
Anti-Fibrotic Agents
Vasodilators
Corticosteroids
CFTR Modulators
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
GSK
Pfizer
Celgene
Novartis
NPS Pharmaceuticals
Auspex Pharmaceuticals
Synageva BioPharma
Roche
Sanofi
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Orphan Lung Diseases Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Immunosuppressants
1.2.3 Anti-Inflammatory Drugs
1.2.4 Anti-Fibrotic Agents
1.2.5 Vasodilators
1.2.6 Corticosteroids
1.2.7 CFTR Modulators
1.2.8 Others
1.3 Market by Application
1.3.1 Global Orphan Lung Diseases Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Orphan Lung Diseases Treatment Market Perspective (2016-2027)
2.2 Orphan Lung Diseases Treatment Growth Trends by Regions
2.2.1 Orphan Lung Diseases Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Orphan Lung Diseases Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Orphan Lung Diseases Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Orphan Lung Diseases Treatment Industry Dynamic
2.3.1 Orphan Lung Diseases Treatment Market Trends
2.3.2 Orphan Lung Diseases Treatment Market Drivers
2.3.3 Orphan Lung Diseases Treatment Market Challenges
2.3.4 Orphan Lung Diseases Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Orphan Lung Diseases Treatment Players by Revenue
3.1.1 Global Top Orphan Lung Diseases Treatment Players by Revenue (2016-2021)
3.1.2 Global Orphan Lung Diseases Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Orphan Lung Diseases Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Orphan Lung Diseases Treatment Revenue
3.4 Global Orphan Lung Diseases Treatment Market Concentration Ratio
3.4.1 Global Orphan Lung Diseases Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Orphan Lung Diseases Treatment Revenue in 2020
3.5 Orphan Lung Diseases Treatment Key Players Head office and Area Served
3.6 Key Players Orphan Lung Diseases Treatment Product Solution and Service
3.7 Date of Enter into Orphan Lung Diseases Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Orphan Lung Diseases Treatment Breakdown Data by Type
4.1 Global Orphan Lung Diseases Treatment Historic Market Size by Type (2016-2021)
4.2 Global Orphan Lung Diseases Treatment Forecasted Market Size by Type (2022-2027)
5 Orphan Lung Diseases Treatment Breakdown Data by Application
5.1 Global Orphan Lung Diseases Treatment Historic Market Size by Application (2016-2021)
5.2 Global Orphan Lung Diseases Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Orphan Lung Diseases Treatment Market Size (2016-2027)
6.2 North America Orphan Lung Diseases Treatment Market Size by Type
6.2.1 North America Orphan Lung Diseases Treatment Market Size by Type (2016-2021)
6.2.2 North America Orphan Lung Diseases Treatment Market Size by Type (2022-2027)
6.2.3 North America Orphan Lung Diseases Treatment Market Size by Type (2016-2027)
6.3 North America Orphan Lung Diseases Treatment Market Size by Application
6.3.1 North America Orphan Lung Diseases Treatment Market Size by Application (2016-2021)
6.3.2 North America Orphan Lung Diseases Treatment Market Size by Application (2022-2027)
6.3.3 North America Orphan Lung Diseases Treatment Market Size by Application (2016-2027)
6.4 North America Orphan Lung Diseases Treatment Market Size by Country
6.4.1 North America Orphan Lung Diseases Treatment Market Size by Country (2016-2021)
6.4.2 North America Orphan Lung Diseases Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Orphan Lung Diseases Treatment Market Size (2016-2027)
7.2 Europe Orphan Lung Diseases Treatment Market Size by Type
7.2.1 Europe Orphan Lung Diseases Treatment Market Size by Type (2016-2021)
7.2.2 Europe Orphan Lung Diseases Treatment Market Size by Type (2022-2027)
7.2.3 Europe Orphan Lung Diseases Treatment Market Size by Type (2016-2027)
7.3 Europe Orphan Lung Diseases Treatment Market Size by Application
7.3.1 Europe Orphan Lung Diseases Treatment Market Size by Application (2016-2021)
7.3.2 Europe Orphan Lung Diseases Treatment Market Size by Application (2022-2027)
7.3.3 Europe Orphan Lung Diseases Treatment Market Size by Application (2016-2027)
7.4 Europe Orphan Lung Diseases Treatment Market Size by Country
7.4.1 Europe Orphan Lung Diseases Treatment Market Size by Country (2016-2021)
7.4.2 Europe Orphan Lung Diseases Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Orphan Lung Diseases Treatment Market Size (2016-2027)
8.2 Asia-Pacific Orphan Lung Diseases Treatment Market Size by Type
8.2.1 Asia-Pacific Orphan Lung Diseases Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Orphan Lung Diseases Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Orphan Lung Diseases Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Orphan Lung Diseases Treatment Market Size by Application
8.3.1 Asia-Pacific Orphan Lung Diseases Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Orphan Lung Diseases Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Orphan Lung Diseases Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Orphan Lung Diseases Treatment Market Size by Region
8.4.1 Asia-Pacific Orphan Lung Diseases Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Orphan Lung Diseases Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Orphan Lung Diseases Treatment Market Size (2016-2027)
9.2 Latin America Orphan Lung Diseases Treatment Market Size by Type
9.2.1 Latin America Orphan Lung Diseases Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Orphan Lung Diseases Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Orphan Lung Diseases Treatment Market Size by Type (2016-2027)
9.3 Latin America Orphan Lung Diseases Treatment Market Size by Application
9.3.1 Latin America Orphan Lung Diseases Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Orphan Lung Diseases Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Orphan Lung Diseases Treatment Market Size by Application (2016-2027)
9.4 Latin America Orphan Lung Diseases Treatment Market Size by Country
9.4.1 Latin America Orphan Lung Diseases Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Orphan Lung Diseases Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Orphan Lung Diseases Treatment Market Size (2016-2027)
10.2 Middle East & Africa Orphan Lung Diseases Treatment Market Size by Type
10.2.1 Middle East & Africa Orphan Lung Diseases Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Orphan Lung Diseases Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Orphan Lung Diseases Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Orphan Lung Diseases Treatment Market Size by Application
10.3.1 Middle East & Africa Orphan Lung Diseases Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Orphan Lung Diseases Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Orphan Lung Diseases Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Orphan Lung Diseases Treatment Market Size by Country
10.4.1 Middle East & Africa Orphan Lung Diseases Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Orphan Lung Diseases Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 GSK Business Overview
11.1.3 GSK Orphan Lung Diseases Treatment Introduction
11.1.4 GSK Revenue in Orphan Lung Diseases Treatment Business (2016-2021)
11.1.5 GSK Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Orphan Lung Diseases Treatment Introduction
11.2.4 Pfizer Revenue in Orphan Lung Diseases Treatment Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 Celgene
11.3.1 Celgene Company Details
11.3.2 Celgene Business Overview
11.3.3 Celgene Orphan Lung Diseases Treatment Introduction
11.3.4 Celgene Revenue in Orphan Lung Diseases Treatment Business (2016-2021)
11.3.5 Celgene Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Orphan Lung Diseases Treatment Introduction
11.4.4 Novartis Revenue in Orphan Lung Diseases Treatment Business (2016-2021)
11.4.5 Novartis Recent Development
11.5 NPS Pharmaceuticals
11.5.1 NPS Pharmaceuticals Company Details
11.5.2 NPS Pharmaceuticals Business Overview
11.5.3 NPS Pharmaceuticals Orphan Lung Diseases Treatment Introduction
11.5.4 NPS Pharmaceuticals Revenue in Orphan Lung Diseases Treatment Business (2016-2021)
11.5.5 NPS Pharmaceuticals Recent Development
11.6 Auspex Pharmaceuticals
11.6.1 Auspex Pharmaceuticals Company Details
11.6.2 Auspex Pharmaceuticals Business Overview
11.6.3 Auspex Pharmaceuticals Orphan Lung Diseases Treatment Introduction
11.6.4 Auspex Pharmaceuticals Revenue in Orphan Lung Diseases Treatment Business (2016-2021)
11.6.5 Auspex Pharmaceuticals Recent Development
11.7 Synageva BioPharma
11.7.1 Synageva BioPharma Company Details
11.7.2 Synageva BioPharma Business Overview
11.7.3 Synageva BioPharma Orphan Lung Diseases Treatment Introduction
11.7.4 Synageva BioPharma Revenue in Orphan Lung Diseases Treatment Business (2016-2021)
11.7.5 Synageva BioPharma Recent Development
11.8 Roche
11.8.1 Roche Company Details
11.8.2 Roche Business Overview
11.8.3 Roche Orphan Lung Diseases Treatment Introduction
11.8.4 Roche Revenue in Orphan Lung Diseases Treatment Business (2016-2021)
11.8.5 Roche Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Details
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Orphan Lung Diseases Treatment Introduction
11.9.4 Sanofi Revenue in Orphan Lung Diseases Treatment Business (2016-2021)
11.9.5 Sanofi Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Orphan Lung Diseases Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Immunosuppressants
Table 3. Key Players of Anti-Inflammatory Drugs
Table 4. Key Players of Anti-Fibrotic Agents
Table 5. Key Players of Vasodilators
Table 6. Key Players of Corticosteroids
Table 7. Key Players of CFTR Modulators
Table 8. Key Players of Others
Table 9. Global Orphan Lung Diseases Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Orphan Lung Diseases Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Orphan Lung Diseases Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global Orphan Lung Diseases Treatment Market Share by Regions (2016-2021)
Table 13. Global Orphan Lung Diseases Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global Orphan Lung Diseases Treatment Market Share by Regions (2022-2027)
Table 15. Orphan Lung Diseases Treatment Market Trends
Table 16. Orphan Lung Diseases Treatment Market Drivers
Table 17. Orphan Lung Diseases Treatment Market Challenges
Table 18. Orphan Lung Diseases Treatment Market Restraints
Table 19. Global Orphan Lung Diseases Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global Orphan Lung Diseases Treatment Market Share by Players (2016-2021)
Table 21. Global Top Orphan Lung Diseases Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Orphan Lung Diseases Treatment as of 2020)
Table 22. Ranking of Global Top Orphan Lung Diseases Treatment Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by Orphan Lung Diseases Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Orphan Lung Diseases Treatment Product Solution and Service
Table 26. Date of Enter into Orphan Lung Diseases Treatment Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Orphan Lung Diseases Treatment Market Size by Type (2016-2021) (US$ Million)
Table 29. Global Orphan Lung Diseases Treatment Revenue Market Share by Type (2016-2021)
Table 30. Global Orphan Lung Diseases Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global Orphan Lung Diseases Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global Orphan Lung Diseases Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global Orphan Lung Diseases Treatment Revenue Market Share by Application (2016-2021)
Table 34. Global Orphan Lung Diseases Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global Orphan Lung Diseases Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America Orphan Lung Diseases Treatment Market Size by Type (2016-2021) (US$ Million)
Table 37. North America Orphan Lung Diseases Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America Orphan Lung Diseases Treatment Market Size by Application (2016-2021) (US$ Million)
Table 39. North America Orphan Lung Diseases Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America Orphan Lung Diseases Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America Orphan Lung Diseases Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe Orphan Lung Diseases Treatment Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe Orphan Lung Diseases Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe Orphan Lung Diseases Treatment Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe Orphan Lung Diseases Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe Orphan Lung Diseases Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe Orphan Lung Diseases Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Orphan Lung Diseases Treatment Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific Orphan Lung Diseases Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Orphan Lung Diseases Treatment Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific Orphan Lung Diseases Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Orphan Lung Diseases Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific Orphan Lung Diseases Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America Orphan Lung Diseases Treatment Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America Orphan Lung Diseases Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America Orphan Lung Diseases Treatment Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America Orphan Lung Diseases Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America Orphan Lung Diseases Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America Orphan Lung Diseases Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Orphan Lung Diseases Treatment Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa Orphan Lung Diseases Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Orphan Lung Diseases Treatment Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa Orphan Lung Diseases Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Orphan Lung Diseases Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa Orphan Lung Diseases Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 66. GSK Company Details
Table 67. GSK Business Overview
Table 68. GSK Orphan Lung Diseases Treatment Product
Table 69. GSK Revenue in Orphan Lung Diseases Treatment Business (2016-2021) & (US$ Million)
Table 70. GSK Recent Development
Table 71. Pfizer Company Details
Table 72. Pfizer Business Overview
Table 73. Pfizer Orphan Lung Diseases Treatment Product
Table 74. Pfizer Revenue in Orphan Lung Diseases Treatment Business (2016-2021) & (US$ Million)
Table 75. Pfizer Recent Development
Table 76. Celgene Company Details
Table 77. Celgene Business Overview
Table 78. Celgene Orphan Lung Diseases Treatment Product
Table 79. Celgene Revenue in Orphan Lung Diseases Treatment Business (2016-2021) & (US$ Million)
Table 80. Celgene Recent Development
Table 81. Novartis Company Details
Table 82. Novartis Business Overview
Table 83. Novartis Orphan Lung Diseases Treatment Product
Table 84. Novartis Revenue in Orphan Lung Diseases Treatment Business (2016-2021) & (US$ Million)
Table 85. Novartis Recent Development
Table 86. NPS Pharmaceuticals Company Details
Table 87. NPS Pharmaceuticals Business Overview
Table 88. NPS Pharmaceuticals Orphan Lung Diseases Treatment Product
Table 89. NPS Pharmaceuticals Revenue in Orphan Lung Diseases Treatment Business (2016-2021) & (US$ Million)
Table 90. NPS Pharmaceuticals Recent Development
Table 91. Auspex Pharmaceuticals Company Details
Table 92. Auspex Pharmaceuticals Business Overview
Table 93. Auspex Pharmaceuticals Orphan Lung Diseases Treatment Product
Table 94. Auspex Pharmaceuticals Revenue in Orphan Lung Diseases Treatment Business (2016-2021) & (US$ Million)
Table 95. Auspex Pharmaceuticals Recent Development
Table 96. Synageva BioPharma Company Details
Table 97. Synageva BioPharma Business Overview
Table 98. Synageva BioPharma Orphan Lung Diseases Treatment Product
Table 99. Synageva BioPharma Revenue in Orphan Lung Diseases Treatment Business (2016-2021) & (US$ Million)
Table 100. Synageva BioPharma Recent Development
Table 101. Roche Company Details
Table 102. Roche Business Overview
Table 103. Roche Revenue in Orphan Lung Diseases Treatment Business (2016-2021) & (US$ Million)
Table 104. Roche Recent Development
Table 105. Sanofi Company Details
Table 106. Sanofi Business Overview
Table 107. Sanofi Orphan Lung Diseases Treatment Product
Table 108. Sanofi Revenue in Orphan Lung Diseases Treatment Business (2016-2021) & (US$ Million)
Table 109. Sanofi Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Orphan Lung Diseases Treatment Market Share by Type: 2020 VS 2027
Figure 2. Immunosuppressants Features
Figure 3. Anti-Inflammatory Drugs Features
Figure 4. Anti-Fibrotic Agents Features
Figure 5. Vasodilators Features
Figure 6. Corticosteroids Features
Figure 7. CFTR Modulators Features
Figure 8. Others Features
Figure 9. Global Orphan Lung Diseases Treatment Market Share by Application: 2020 VS 2027
Figure 10. Hospital Pharmacies Case Studies
Figure 11. Retail Pharmacies Case Studies
Figure 12. Online Pharmacies Case Studies
Figure 13. Orphan Lung Diseases Treatment Report Years Considered
Figure 14. Global Orphan Lung Diseases Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Orphan Lung Diseases Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Orphan Lung Diseases Treatment Market Share by Regions: 2020 VS 2027
Figure 17. Global Orphan Lung Diseases Treatment Market Share by Regions (2022-2027)
Figure 18. Global Orphan Lung Diseases Treatment Market Share by Players in 2020
Figure 19. Global Top Orphan Lung Diseases Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Orphan Lung Diseases Treatment as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Orphan Lung Diseases Treatment Revenue in 2020
Figure 21. Global Orphan Lung Diseases Treatment Revenue Market Share by Type (2016-2021)
Figure 22. Global Orphan Lung Diseases Treatment Revenue Market Share by Type (2022-2027)
Figure 23. North America Orphan Lung Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Orphan Lung Diseases Treatment Market Share by Type (2016-2027)
Figure 25. North America Orphan Lung Diseases Treatment Market Share by Application (2016-2027)
Figure 26. North America Orphan Lung Diseases Treatment Market Share by Country (2016-2027)
Figure 27. United States Orphan Lung Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Orphan Lung Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Orphan Lung Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Orphan Lung Diseases Treatment Market Share by Type (2016-2027)
Figure 31. Europe Orphan Lung Diseases Treatment Market Share by Application (2016-2027)
Figure 32. Europe Orphan Lung Diseases Treatment Market Share by Country (2016-2027)
Figure 33. Germany Orphan Lung Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Orphan Lung Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Orphan Lung Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Orphan Lung Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Orphan Lung Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Orphan Lung Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Orphan Lung Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Orphan Lung Diseases Treatment Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Orphan Lung Diseases Treatment Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Orphan Lung Diseases Treatment Market Share by Region (2016-2027)
Figure 43. China Orphan Lung Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Orphan Lung Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Orphan Lung Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Orphan Lung Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Orphan Lung Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Orphan Lung Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Orphan Lung Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Orphan Lung Diseases Treatment Market Share by Type (2016-2027)
Figure 51. Latin America Orphan Lung Diseases Treatment Market Share by Application (2016-2027)
Figure 52. Latin America Orphan Lung Diseases Treatment Market Share by Country (2016-2027)
Figure 53. Mexico Orphan Lung Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Orphan Lung Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Orphan Lung Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Orphan Lung Diseases Treatment Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Orphan Lung Diseases Treatment Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Orphan Lung Diseases Treatment Market Share by Country (2016-2027)
Figure 59. Turkey Orphan Lung Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Orphan Lung Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Orphan Lung Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. GSK Revenue Growth Rate in Orphan Lung Diseases Treatment Business (2016-2021)
Figure 63. Pfizer Revenue Growth Rate in Orphan Lung Diseases Treatment Business (2016-2021)
Figure 64. Celgene Revenue Growth Rate in Orphan Lung Diseases Treatment Business (2016-2021)
Figure 65. Novartis Revenue Growth Rate in Orphan Lung Diseases Treatment Business (2016-2021)
Figure 66. NPS Pharmaceuticals Revenue Growth Rate in Orphan Lung Diseases Treatment Business (2016-2021)
Figure 67. Auspex Pharmaceuticals Revenue Growth Rate in Orphan Lung Diseases Treatment Business (2016-2021)
Figure 68. Synageva BioPharma Revenue Growth Rate in Orphan Lung Diseases Treatment Business (2016-2021)
Figure 69. Roche Revenue Growth Rate in Orphan Lung Diseases Treatment Business (2016-2021)
Figure 70. Sanofi Revenue Growth Rate in Orphan Lung Diseases Treatment Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed